Oncolytics Biotech Inc. Stock Nasdaq
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 857K 626K | Sales 2025 * | 6.68M 4.88M | Capitalization | 112M 82.08M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.3M | Net income 2025 * | -40M -29.22M | EV / Sales 2024 * | 131 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.8 x |
P/E ratio 2024 * |
-3.36
x | P/E ratio 2025 * |
-3.39
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
+1.93% | 42.59B | |
+7.50% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.12% | 24.81B | |
-24.10% | 18.17B | |
+27.19% | 12.05B | |
-3.09% | 11.7B | |
+6.74% | 11.1B |